These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1356242)

  • 21. The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats.
    Lonsdale D; Nylen K; McIntyre Burnham W
    Brain Res; 2006 Jul; 1101(1):110-6. PubMed ID: 16784731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats.
    Folbergrová J
    Exp Neurol; 1997 Jun; 145(2 Pt 1):442-50. PubMed ID: 9217080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation of CHF3381 as a novel antiepileptic agent.
    Villetti G; Bregola G; Bassani F; Bergamaschi M; Rondelli I; Pietra C; Simonato M
    Neuropharmacology; 2001 Jun; 40(7):866-78. PubMed ID: 11378157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-epileptic effect of 3-aminopropylarsonate on electrically-kindled and N-methyl-D-aspartate-kindled amygdala.
    Abdul-Ghani AS; Attwell PJ; Bradford HF
    Brain Res; 1996 Dec; 742(1-2):305-12. PubMed ID: 9117409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression.
    Barton ME; White HS
    Epilepsy Res; 2004 Mar; 59(1):1-12. PubMed ID: 15135162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amygdaloid kindling by repeated focal N-methyl-D-aspartate administration: comparison with electrical kindling.
    Croucher MJ; Cotterell KL; Bradford HF
    Eur J Pharmacol; 1995 Nov; 286(3):265-71. PubMed ID: 8608788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kindled rats are more sensitive than non-kindled rats to the behavioural effects of combined treatment with MK-801 and valproate.
    Dziki M; Hönack D; Löscher W
    Eur J Pharmacol; 1992 Nov; 222(2-3):273-8. PubMed ID: 1360405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the anticonvulsant properties of F-721.
    Swinyard EA; Wolf HH; White HS; Skeen GA; Stark LG; Albertson T; Pong SF; Drust EG
    Epilepsy Res; 1993 May; 15(1):35-45. PubMed ID: 8391982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures.
    Holmes KH; Bilkey DK; Laverty R; Goddard GV
    Brain Res; 1990 Jan; 506(2):227-35. PubMed ID: 1967965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds.
    Croucher MJ; Bradford HF
    Brain Res; 1991 Mar; 543(1):91-6. PubMed ID: 1647257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of sex hormone antagonists on the anticonvulsant action of conventional antiepileptic drugs against amygdala-kindled seizures in male and female rats.
    Borowicz KK; Kleinrok Z; Czuczwar SJ
    Eur Neuropsychopharmacol; 2003 Aug; 13(4):257-65. PubMed ID: 12888185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model.
    Zellinger C; Salvamoser JD; Soerensen J; van Vliet EA; Aronica E; Gorter J; Potschka H
    Epilepsy Res; 2014 May; 108(4):634-43. PubMed ID: 24656981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiepileptogenic action of 7-chlorokynurenic acid on amygdala kindling of rats.
    Namba T; Morimoto K; Yamada N; Otsuki S
    Pharmacol Biochem Behav; 1993 Oct; 46(2):275-81. PubMed ID: 8265681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
    Wlaź P
    Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anticonvulsant effects of allopregnanolone against amygdala-kindled seizures in female rats.
    Lonsdale D; Burnham WM
    Neurosci Lett; 2007 Jan; 411(2):147-51. PubMed ID: 17084970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
    D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
    Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures.
    Tober C; Rostock A; Rundfeldt C; Bartsch R
    Eur J Pharmacol; 1996 May; 303(3):163-9. PubMed ID: 8813562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.